Abstract
PURPOSE: Toxoplasma gondii is an important cause of morbidity and mortality in solid organ transplant recipients. Patients with a serologic mismatch (donor positive/ recipient negative) are at higher risk for toxoplasmosis, and prophylaxis has been effective for certain solid organ transplant recipients. The incidence of toxoplasma mismatch and the efficacy of prophylaxis have not been studied in lung transplant recipients. Our aim is to determine the incidence of T. gondii serologic mismatch in the lung transplant population and report the incidence of toxoplasmosis in patients receiving pyrimethamine and leukovorin prophylaxis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
